When comparing C9-ALS patients with non-C9-ALS patient, one study reported that C9-ALS brains showed more extensive microglial pathology in the white matter of the medulla and the motor cortex (as measured by CD68 and Iba1 immunoreactivity) [265]. The gene discussed is AIF1; the disease is amyotrophic lateral sclerosis.